AMGN · NASDAQ · Healthcare · Drug Manufacturers - General

Amgen

—Past month
Price unavailable
  • 52W range288.00–450.98
  • P/E ratio27.28
  • Market cap242.05B

Latest news

Loading...

About

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and ora...

amgen.com